Heartflow received nationwide UnitedHealthcare coverage for its AI CT plaque analysis software and announced plans for a $200M IPO at a $1.3B valuation.
Key Details
- 1UnitedHealthcare will provide nationwide coverage for Heartflow's CT-based plaque analysis software, effective October 1.
- 2Coverage applies to all UnitedHealthcare plans, including commercial, Medicare Advantage, and dual-eligible offerings.
- 3Heartflow aims to raise up to $212.5 million by offering 12.5 million shares at $15–$17 per share in its IPO.
- 4Company generated about $43 million in Q2 2025, up 40% year-over-year.
- 5Heartflow's platform has assessed over 400,000 patients for coronary artery disease as of March 31, 2025.
- 6The US market opportunity for Heartflow's products is estimated at $5 billion.
Why It Matters
Nationwide insurer coverage and a strong IPO position solidify Heartflow's AI solution as a standard in coronary CT interpretation. This represents a significant step in the adoption and reimbursement of radiology AI, paving the way for broader clinical and commercial implementation.
Source
Radiology Business
Related News
•AuntMinnie
Study: Computer Vision Models Best LLMs in Chest CT Breast Abnormality Detection
Computer vision models (CVMs) surpass large language models (LLMs) in accurately labeling incidental breast abnormalities on chest CT scans.
•Radiology Business
Private Equity Backs AIRS Medical to Expand MRI AI Globally
TA Associates is investing in AIRS Medical to accelerate its global expansion of AI-powered MRI efficiency solutions.
•Cardiovascular Business
Radiology Maintains Lead in FDA-Cleared AI Algorithms, Cardiology Follows
Radiology remains the top specialty for FDA-cleared AI, with cardiology as a strong second, particularly in cardiovascular imaging.